Griselimycin

26034-16-2

(2S,4R)-1-(N-Acetyl-N-methyl-L-valyl)-N,4-dimethyl-N-((2R,6S,9S,10R,16R,18aS,24S,27S,29aS)-6,16,27-triisobutyl-24-isopropyl-2,10,17,25-tetramethyl-5,8,12,15,18,23,26,29-octaoxohexacosahydro-1H,12H-dipyrrolo[2,1-i:2',1'-r][1]oxa[4,7,10,13,16,19,22]heptaazacyclopentacosin-9-yl)pyrrolidine-2-carboxamide; Glycine, N-acetyl-N-methyl-L-valyl-(4R)-4-methyl-L-prolyl-N-methyl-L-threonyl-L-leucyl-(4R)-4-methyl-L-prolyl-L-leucyl-N-methyl-L-valyl-L-prolyl-N-methyl-D-leucyl-, (10→3)-lactone; Grizelimycin; N-[N-[1-[N-[N-[1-[N-[N-[1-(N-Acetyl-N-methyl-L-valyl)-trans-4-methyl-L-prolyl]-N-methyl-L-threonyl]-L-leucyl]-trans-4-methyl-L-prolyl]-L-leucyl]-N-methyl-L-valyl]-L-prolyl]-N-methyl-D-leucyl]glycine ψ-lactone;